These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9249126)

  • 1. The effects of chronic tacrine therapy on d-tubocurarine blockade in the soleus and tibialis muscles of the rat.
    Ibebunjo C; Donati F; Fox GS; Eshelby D; Tchervenkov JI
    Anesth Analg; 1997 Aug; 85(2):431-6. PubMed ID: 9249126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tacrine does not alter the potency of succinylcholine in the rat.
    Ibebunjo C; Eshelby D; Donati F; Fox GS; Tchervenkov JI
    Can J Anaesth; 1997 Sep; 44(9):1021-6. PubMed ID: 9305568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermal injury induces greater resistance to d-tubocurarine in local rather than in distant muscles in the rat.
    Ibebunjo C; Martyn JA
    Anesth Analg; 2000 Nov; 91(5):1243-9. PubMed ID: 11049916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of d-tubocurarine pretreatment on succinylcholine twitch augmentation and neuromuscular blockade.
    Szalados JE; Donati F; Bevan DR
    Anesth Analg; 1990 Jul; 71(1):55-9. PubMed ID: 2363529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prednisolone-induced muscle dysfunction is caused more by atrophy than by altered acetylcholine receptor expression.
    Shin YS; Fink H; Khiroya R; Ibebunjo C; Martyn J
    Anesth Analg; 2000 Aug; 91(2):322-8. PubMed ID: 10910842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged d-tubocurarine infusion and/or immobilization cause upregulation of acetylcholine receptors and hyperkalemia to succinylcholine in rats.
    Yanez P; Martyn JA
    Anesthesiology; 1996 Feb; 84(2):384-91. PubMed ID: 8602670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic intraperitoneal endotoxin treatment in rats induces resistance to d-tubocurarine, but does not produce up-regulation of acetylcholine receptors.
    Hinohara H; Morita T; Okano N; Kunimoto F; Goto F
    Acta Anaesthesiol Scand; 2003 Mar; 47(3):335-41. PubMed ID: 12648201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single injection of botulinum toxin decreases the margin of safety of neurotransmission at local and distant sites.
    Frick CG; Fink H; Blobner M; Martyn J
    Anesth Analg; 2012 Jan; 114(1):102-9. PubMed ID: 22003222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms for the paradoxical resistance to d-tubocurarine during immobilization-induced muscle atrophy.
    Ibebunjo C; Nosek MT; Itani MS; Martyn JA
    J Pharmacol Exp Ther; 1997 Nov; 283(2):443-51. PubMed ID: 9353356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic interaction between pantoprazole and vecuronium at neuromuscular junction.
    Vadgama VK; Patel YA; Patel TK; Tripathi CB
    Auton Autacoid Pharmacol; 2011; 31(1-2):31-5. PubMed ID: 21342416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WITHDRAWN: Tacrine for Alzheimer's disease.
    Qizilbash N; Birks J; Lopez Arrieta J; Lewington S; Szeto S
    Cochrane Database Syst Rev; 2007 Jul; (3):CD000202. PubMed ID: 17636619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tacrine].
    Dávila C; Viteri C; de Castro P
    Rev Med Univ Navarra; 1997; 41(1):58-64. PubMed ID: 9527715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of lipopolysaccharide endotoxin produced from Escherichia coli with D-tubocurarine at the nicotinic2 receptor and adenosine 3':5' cyclic monophosphate during physiological contraction in skeletal muscle.
    Tomera JF
    Food Chem Toxicol; 1996 Jan; 34(1):63-72. PubMed ID: 8603799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological correlates of the differential responses of muscles to vecuronium.
    Ibebunjo C; Srikant CB; Donati F
    Br J Anaesth; 1999 Aug; 83(2):284-91. PubMed ID: 10618945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrine. Alzheimer's disease and the cholinergic theory. A critical review and results of a new therapy.
    Boller F; Orgogozo JM
    Neurologia; 1995 May; 10(5):194-9. PubMed ID: 7619536
    [No Abstract]   [Full Text] [Related]  

  • 16. Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
    Camps P; El Achab R; Görbig DM; Morral J; Muñoz-Torrero D; Badia A; Eladi Baños J; Vivas NM; Barril X; Orozco M; Luque FJ
    J Med Chem; 1999 Aug; 42(17):3227-42. PubMed ID: 10464010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease.
    Schneider LS; Farlow MR; Henderson VW; Pogoda JM
    Neurology; 1996 Jun; 46(6):1580-4. PubMed ID: 8649552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple actions of THA on cholinergic neurotransmission in Alzheimer brains.
    Nordberg A; Nilsson-Håkansson L; Adem A; Lai Z; Winblad B
    Prog Clin Biol Res; 1989; 317():1169-78. PubMed ID: 2557636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.
    Gauthier S; Bouchard R; Lamontagne A; Bailey P; Bergman H; Ratner J; Tesfaye Y; Saint-Martin M; Bacher Y; Carrier L
    N Engl J Med; 1990 May; 322(18):1272-6. PubMed ID: 2183056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to d-tubocurarine in lower motor neuron injury is related to increased acetylcholine receptors at the neuromuscular junction.
    Hogue CW; Itani MS; Martyn JA
    Anesthesiology; 1990 Oct; 73(4):703-9. PubMed ID: 2221439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.